| Theme |
How Do You Choose Treatment Strategies for IBD Patients with a Critical Situation? |
| Title |
Treatment Strategy for Steroid—refractory Ulcerative Colitis : When Should Operation Be Decided ? |
| Author |
Takeshi Ueda |
Department of Surgery, Nara Medical University |
| Author |
Hisao Fujii |
Department of Surgery, Nara Medical University / Department of Endoscopy and Ultrasound, Nara Medical University |
| Author |
Fumikazu Koyama |
Department of Surgery, Nara Medical University / Department of Endoscopy and Ultrasound, Nara Medical University |
| Author |
Takashi Inoue |
Department of Surgery, Nara Medical University |
| Author |
Takayuki Nakamoto |
Department of Surgery, Nara Medical University |
| Author |
Yoshiyuki Nakajima |
Department of Surgery, Nara Medical University |
| [ Summary ] |
The treatment strategy for steroid‒refractory ulcerative colitis (UC) is unclear. Whether treatments such as leukocytapheresis, anti‒TNF agents, and tacrolimus are effective remains to be elucidated. In our institution, the response rate tended to be higher in patients treated with tacrolimus for severely active UC. For patients with moderately active UC, we tend to use anti‒TNF agents in consideration of maintenance of remission. On the other hand, early operation is important for patients with severe UC.
The purpose of treatment is to improve patient' quality of life. |